Indian Immunologicals Ltd rolls out Havisure, India's first indigenous Hepatitis-A vaccine. The two-dose inactivated virus vaccine, developed over eight years, is priced at Rs 2,150 per dose. Extensive clinical trials have shown that Havisure is safe and efficacious for pediatric, adolescent, and adult use.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/DUd9A0x
https://ift.tt/S9DLkro
